History of Testosterone Use in Women

Early scientific evidence showing that testosterone as the libido enhancing hormone in women was reported during the 1940′s and 50′s.

Early scientific evidence showing that testosterone as the libido enhancing hormone in women was reported during the 1940's and 50's.

It was in the mid-1970′s that the vital role of our ovaries is a testosterone production. Subsequent research established that sexual function declines following oophorectomy (surgical removal of the ovaries). Additional research has established that administration of testosterone reversed the decline in sexuality as a result of oophorectomy.

Prior to 2000, the majority of medical research conducted with the use of testosterone in women centered on the implants and injections of it. While therapeutically effective, these dose forms have significant shortcomings when used by women.

They produce extremely high levels in women even when administered in reduced doses (often 10 times higher than normal levels) and have the potential for causing significant side-effects including masculisation, male pattern baldness, hirsutism (body hair growth), acne and permanently deepened voice changes.

Many women who suffer from loss of libido date their problem to removal of their ovaries. This surgery in both pre- and post-menopausal women results in an immediate 50% reduction in testosterone levels.

Standard medical practice over the past 40 years has been to supplement women with oestrogen after removal of the ovaries, but ignores the hormones testosterone and progesterone.

Estrogen therapy alone usually does not restore libido in oophorectomized (removal of the ovaries) women. Medical studies comparing estrogen alone with estrogen plus testosterone have shown a significant improvement in energy and libido with the combined treatment without side effects. Additional medical trials have also shown that it has an additive effect on bone density when combined with estrogen – a very important consideration for prevention of osteoporosis.

The problem of reduced libido and unexplained fatigue is not confined to women who have undergone surgical removal of the ovaries.

Pre- and post-menopausal women with intact ovaries can also have low testosterone levels and experience the same symptoms for low sexual desire and lethargy as oophorectomized women. Testosterone treatment can result in significant improvements in the quality of life and sexual fulfilment if you are a sufferer.

Female Sexual Dysfunction

There is universal acceptance amongst reproductive endocrinologists, gynecologists and those specializing in the area of women’s health that sexual dysfunction affects a substantial proportion of women. This has significant psychological impacts and can adversely affect social and personal relationships. Various studies indicate that between 30-43% of women aged between 18 and 59 years of age experience some degree of sexual dysfunction.

Female sexual dysfunction is a multi-layered condition that requires careful evaluation and may involve several strategies to manage effectively.

Classifications and defining criteria for sexual dysfunction in women have been established over the past few years. Validated assessment scales and questionnaires have been developed to assist with the diagnosis and monitoring of treatments for sexual dysfunction.

Female sexual dysfunction is a multi-layered condition that requires careful evaluation and may involve several strategies to manage effectively. The hormonal profile of the subject is part of the assessment to determine the origins of sexual dysfunction.

The testosterone is the hormone with the greatest influence on human sexual function.

It is a vital component of your sexuality, enhancing interest in initiating sexual activity and response to sexual stimulation. It is also the hormone associated with greater well-being, with increased energy and vitality and with reduced anxiety and depression.

Testosterone Availability

No testosterone product has been approved in the USA or Europe for the treatment of poor libido in women. Male approved these products are usually given to women in reduced doses. This is a common practice by doctors around the world – a practice called “off-label” usage.

The situation in Australia is distinctly different with a 1% testosterone cream (Testofeme manufactured by Affiliates International) available for use in women. Testofeme is by far the most popular testosterone treatment option for use in women because it involves no surgery, no pain, is applied by the woman in the privacy of her own home and the dose is accurately controlled.

The transdermal testosterone patch, Intrinsa® (Procter and Gamble, USA) and the topical testosterone cream (TestoFeme, Affiliates International, Australia) lead the way in this exciting area of female healthcare.
Purchase your TestoFeme Plus Natural 1% Testosterone cream for Women

Contrary to popular belief, the most common male sexual dysfunction is premature ejaculation. However, many men are more reluctant to seek medical help for this psychologically damaging condition than for other sexual dysfunctions. This is one of the reasons why, for a long time, there was no medication available for the treatment of PE. Up until now, that is. Finally, researchers have found a solution for PE with the development of the revolutionary medication Dapoxetine. As the only approved medication for the treatment of PE, these pills help men regain control over the ejaculation process by interfering with the uptake of serotonin in the brain. Serotonin has been found to play an important role in the timing of ejaculation and by preventing its reabsorption; men can more easily hold back before reaching ‘the point of no return’. The revolutionary results include better control, longer staying power and a boost in self-esteem and sexual relationships. Take control of your love life again with Dapoxetine.